Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-12 5:34 PM View:  | Tranzyme, Inc. (OCRX) | 14-Mar-12 | Market Purchase | 2,392 | $3.00 | $7,164.85 | 4% 55.31K to 57.7K | (95%) |
| 14-Mar-12 5:34 PM View: | Tranzyme, Inc. (OCRX) | 13-Mar-12 | Market Purchase | 4,186 | $2.96 | $12,382.60 | 8% 51.13K to 55.31K | (95%) |
| 14-Mar-12 5:34 PM View: | Tranzyme, Inc. (OCRX) | 12-Mar-12 | Market Purchase | 25,304 | $2.44 | $61,628.70 | 98% 25.82K to 51.13K | (94%) |
| 09-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 08-Mar-12 | Market Purchase | 516 | $30.36 | $15,667.70 | < 1% 227.32K to 227.84K | 174% |
| 09-Mar-12 6:28 PM View: | Genomic Health Inc. (GHDX) | 07-Mar-12 | Market Purchase | 583 | $29.88 | $17,419.60 | < 1% 226.74K to 227.32K | 179% |
| 05-Mar-12 6:27 PM View: | Genomic Health Inc. (GHDX) | 05-Mar-12 | Market Purchase | 4,099 | $30.01 | $122,998.00 | 2% 222.64K to 226.74K | 178% |
| 05-Mar-12 6:27 PM View: | Genomic Health Inc. (GHDX) | 02-Mar-12 | Market Purchase | 2,419 | $29.52 | $71,410.10 | 1% 220.22K to 222.64K | 182% |
| 05-Mar-12 6:27 PM View: | Genomic Health Inc. (GHDX) | 01-Mar-12 | Market Purchase | 405 | $29.47 | $11,935.50 | < 1% 219.82K to 220.22K | 183% |
| 29-Feb-12 5:42 PM View: | Genomic Health Inc. (GHDX) | 29-Feb-12 | Market Purchase | 4,149 | $29.06 | $120,562.00 | 2% 215.67K to 219.82K | 187% |
| 29-Feb-12 5:42 PM View: | Genomic Health Inc. (GHDX) | 28-Feb-12 | Market Purchase | 1,353 | $29.11 | $39,383.80 | < 1% 214.32K to 215.67K | 186% |
| 29-Feb-12 5:42 PM View: | Genomic Health Inc. (GHDX) | 27-Feb-12 | Market Purchase | 974 | $29.03 | $28,275.80 | < 1% 213.34K to 214.32K | 187% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 23-Feb-12 | Market Purchase | 1,639 | $28.12 | $46,094.90 | < 1% 211.7K to 213.34K | 196% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 22-Feb-12 | Market Purchase | 145 | $27.98 | $4,057.26 | < 1% 211.56K to 211.7K | 198% |
| 23-Feb-12 6:08 PM View: | Genomic Health Inc. (GHDX) | 21-Feb-12 | Market Purchase | 1,238 | $27.98 | $34,635.40 | < 1% 210.32K to 211.56K | 198% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 16-Feb-12 | Market Purchase | 4,889 | $29.73 | $145,350.00 | 2% 205.43K to 210.32K | 180% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 15-Feb-12 | Market Purchase | 849 | $28.88 | $24,516.70 | < 1% 204.58K to 205.43K | 189% |
| 16-Feb-12 6:58 PM View: | Genomic Health Inc. (GHDX) | 14-Feb-12 | Market Purchase | 1,475 | $28.44 | $41,944.60 | < 1% 203.11K to 204.58K | 193% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 10-Feb-12 | Market Purchase | 4,225 | $26.59 | $112,343.00 | 2% 198.88K to 203.11K | 213% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 09-Feb-12 | Market Purchase | 1,478 | $26.32 | $38,897.50 | < 1% 197.4K to 198.88K | 217% |
| 10-Feb-12 9:33 PM View: | Genomic Health Inc. (GHDX) | 08-Feb-12 | Market Purchase | 5,340 | $26.20 | $139,904.00 | 3% 192.06K to 197.4K | 218% |
| 03-Feb-12 5:51 PM View: | Ardea Biosciences, Inc. (RDEA) | 01-Feb-12 | Market Purchase | 23,172 | $17.00 | $393,924.00 | 25% 93.28K to 116.45K | 11% |
| 26-Jan-12 6:09 PM View: | Pharmacyclics Inc. (PCYC) | 26-Jan-12 | Market Purchase | 6,304 | $17.93 | $113,049.00 | 3% 189.55K to 195.86K | 1357% |
| 26-Jan-12 6:09 PM View: | Pharmacyclics Inc. (PCYC) | 25-Jan-12 | Market Purchase | 3,246 | $18.53 | $60,152.40 | 2% 186.31K to 189.55K | 1310% |
| 26-Jan-12 6:09 PM View: | Pharmacyclics Inc. (PCYC) | 24-Jan-12 | Market Purchase | 3,395 | $17.95 | $60,954.70 | 2% 182.91K to 186.31K | 1355% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 23-Jan-12 | Market Purchase | 4,273 | $16.87 | $72,097.10 | 2% 178.64K to 182.91K | 1448% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Market Purchase | 6,536 | $16.42 | $107,306.00 | 4% 171.4K to 177.94K | 1491% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 20-Jan-12 | Exercise (in-the money or at-the-money) | 700 | $15.00 | $10,500.00 | < 1% 177.94K to 178.64K | 1642% |
| 23-Jan-12 8:40 PM View: | Pharmacyclics Inc. (PCYC) | 19-Jan-12 | Market Purchase | 938 | $16.05 | $15,055.00 | < 1% 170.47K to 171.4K | 1528% |
| 17-Jan-12 8:43 PM View: | Incyte Corp (INCY) | 13-Jan-12 | Market Purchase | 5,856 | $16.53 | $96,793.70 | 2% 349.98K to 355.84K | 428% |
| 17-Jan-12 8:43 PM View: | Incyte Corp (INCY) | 12-Jan-12 | Market Purchase | 8,769 | $16.26 | $142,615.00 | 3% 341.21K to 349.98K | 437% |
| 09-Jan-12 7:00 PM View: | Trimeris Inc. (GEVA) | 05-Jan-12 | Grant | 29,089 | $25.18 | $732,461.00 | 27% 106.65K to 135.74K | 837% |
| 03-Jan-12 6:04 PM View: | Adolor Corp. (ADLR) | 19-Dec-11 | Disposition (change in control) | 186,272 | $4.25 | $791,656.00 | (100%) 186.27K to 0 | |
| 16-Dec-11 4:28 PM View: | ViroPharma Inc. (VPHM) | 14-Dec-11 | Market Purchase | 7,828 | $27.29 | $213,613.00 | 3% 295.44K to 303.26K | 82% |
| 12-Dec-11 5:22 PM View: | Incyte Corp (INCY) | 09-Dec-11 | Market Purchase | 4,862 | $13.26 | $64,461.70 | 1% 336.35K to 341.21K | 559% |
| 12-Dec-11 5:22 PM View: | Incyte Corp (INCY) | 08-Dec-11 | Market Purchase | 5,965 | $13.46 | $80,282.40 | 2% 330.39K to 336.35K | 549% |
| 07-Dec-11 5:58 PM View: | Incyte Corp (INCY) | 07-Dec-11 | Market Purchase | 3,878 | $13.22 | $51,256.40 | 1% 326.51K to 330.39K | 561% |
| 07-Dec-11 5:58 PM View: | Incyte Corp (INCY) | 06-Dec-11 | Market Purchase | 9,057 | $13.53 | $122,526.00 | 3% 317.45K to 326.51K | 545% |
| 05-Dec-11 6:19 PM View: | Genomic Health Inc. (GHDX) | 05-Dec-11 | Market Purchase | 548 | $28.45 | $15,593.20 | < 1% 191.52K to 192.06K | 193% |
| 07-Dec-11 5:58 PM View: | Incyte Corp (INCY) | 05-Dec-11 | Market Purchase | 28,685 | $13.89 | $398,315.00 | 10% 288.77K to 317.45K | 529% |
| 06-Dec-11 6:08 PM View: | Pharmacyclics Inc. (PCYC) | 02-Dec-11 | Market Purchase | 2,360 | $15.42 | $36,380.90 | 1% 168.11K to 170.47K | 1595% |
| 05-Dec-11 6:19 PM View: | Genomic Health Inc. (GHDX) | 02-Dec-11 | Market Purchase | 2,604 | $28.05 | $73,045.10 | 1% 188.91K to 191.52K | 197% |
| 01-Dec-11 4:33 PM View: | Incyte Corp (INCY) | 01-Dec-11 | Market Purchase | 22,380 | $14.12 | $315,958.00 | 8% 266.39K to 288.77K | 519% |
| 30-Nov-11 6:20 PM View: | Pharmacyclics Inc. (PCYC) | 29-Nov-11 | Market Purchase | 4,383 | $14.18 | $62,133.10 | 3% 163.72K to 168.11K | 1743% |
| 01-Dec-11 4:33 PM View: | Incyte Corp (INCY) | 29-Nov-11 | Market Purchase | 28,890 | $12.21 | $352,819.00 | 12% 237.5K to 266.39K | 615% |
| 30-Nov-11 6:20 PM View: | Pharmacyclics Inc. (PCYC) | 28-Nov-11 | Market Purchase | 4,052 | $13.34 | $54,055.30 | 3% 159.67K to 163.72K | 1858% |
| 23-Nov-11 5:04 PM View: | Pharmacyclics Inc. (PCYC) | 23-Nov-11 | Market Purchase | 747 | $12.76 | $9,531.79 | < 1% 158.92K to 159.67K | 1948% |
| 23-Nov-11 5:00 PM View: | Genomic Health Inc. (GHDX) | 23-Nov-11 | Market Purchase | 539 | $25.83 | $13,923.10 | < 1% 188.37K to 188.91K | 223% |
| 23-Nov-11 5:04 PM View: | Pharmacyclics Inc. (PCYC) | 22-Nov-11 | Market Purchase | 3,492 | $12.78 | $44,639.80 | 2% 155.43K to 158.92K | 1944% |
| 23-Nov-11 5:00 PM View: | Genomic Health Inc. (GHDX) | 22-Nov-11 | Market Purchase | 2,044 | $26.03 | $53,205.70 | 1% 186.33K to 188.37K | 220% |
| 23-Nov-11 5:04 PM View: | Pharmacyclics Inc. (PCYC) | 21-Nov-11 | Market Purchase | 2,778 | $12.07 | $33,526.40 | 2% 152.65K to 155.43K | 2065% |